Propranolol: Reliable Cardiovascular and Anxiety Control
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.16 (0%) | 🛒 Add to cart |
| 20 | $2.26 | $80.32 $45.18 (44%) | 🛒 Add to cart |
| 30 | $1.67 | $120.49 $50.20 (58%) | 🛒 Add to cart |
| 60 | $0.92 | $240.97 $55.22 (77%) | 🛒 Add to cart |
| 90 | $0.67 | $361.46 $60.24 (83%) | 🛒 Add to cart |
| 120 | $0.54 | $481.95 $65.26 (86%) | 🛒 Add to cart |
| 180 | $0.45 | $722.92 $80.32 (89%) | 🛒 Add to cart |
| 270 | $0.37 | $1084.38 $100.41 (91%) | 🛒 Add to cart |
| 360 | $0.33
Best per pill | $1445.84 $120.49 (92%) | 🛒 Add to cart |
| Product dosage: 80mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.52 | $45.18 (0%) | 🛒 Add to cart |
| 20 | $2.51 | $90.36 $50.20 (44%) | 🛒 Add to cart |
| 30 | $1.84 | $135.55 $55.22 (59%) | 🛒 Add to cart |
| 60 | $1.00 | $271.09 $60.24 (78%) | 🛒 Add to cart |
| 90 | $0.73 | $406.64 $65.26 (84%) | 🛒 Add to cart |
| 120 | $0.67 | $542.19 $80.32 (85%) | 🛒 Add to cart |
| 180 | $0.56 | $813.28 $100.41 (88%) | 🛒 Add to cart |
| 270 | $0.46 | $1219.93 $125.51 (90%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $1626.57 $155.63 (90%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
Propranolol is a non-selective beta-adrenergic blocking agent, widely recognized for its efficacy in managing a range of cardiovascular and neurological conditions. As a cornerstone in therapeutic regimens, it operates by competitively inhibiting catecholamine-induced stimulation of beta receptors within the sympathetic nervous system. Its established safety profile and versatility make it a first-line option for hypertension, angina pectoris, arrhythmias, migraine prophylaxis, and essential tremor. Additionally, it is frequently employed off-label for situational anxiety and performance stress, offering symptomatic relief without significant sedation. This comprehensive profile outlines its pharmacological characteristics, clinical applications, and essential safety information for healthcare professionals.
Features
- Active ingredient: Propranolol hydrochloride
- Drug class: Non-selective beta-blocker
- Available forms: Oral tablets (10 mg, 20 mg, 40 mg, 60 mg, 80 mg), extended-release capsules, injectable solution
- Bioavailability: Approximately 25% (subject to first-pass metabolism)
- Half-life: 3–6 hours (standard release); up to 12 hours (extended-release)
- Protein binding: 90%
- Metabolism: Hepatic (primarily CYP2D6, CYP1A2)
- Excretion: Renal
Benefits
- Reduces blood pressure and heart rate, decreasing long-term cardiovascular risk
- Prevents angina episodes by lowering myocardial oxygen demand
- Controls rhythm disturbances such as atrial fibrillation and tachyarrhythmias
- Decreases frequency and severity of migraine headaches
- Alleviates symptoms of essential tremor and situational anxiety
- May improve outcomes post-myocardial infarction when used appropriately
Common use
Propranolol is indicated for the management of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also approved for angina pectoris, supraventricular and ventricular arrhythmias, prophylaxis of migraine headaches, and essential tremor. Off-label uses include treatment of performance anxiety, hyperthyroidism symptoms, portal hypertension, and certain types of tremors or akathisia. Its use in anxiety disorders is particularly valued for attenuating peripheral adrenergic symptoms such as palpitations and tremors without central nervous system depression.
Dosage and direction
Dosage must be individualized based on indication, patient response, and tolerability. For hypertension, initial dosing often begins at 40 mg twice daily, with maintenance doses ranging from 120–240 mg daily in divided doses. For angina, typical starting dose is 80 mg daily in divided doses, increasing gradually to 160–320 mg per day. Migraine prophylaxis usually involves 80 mg daily in divided doses, which may be increased up to 240 mg daily if needed. Extended-release formulations allow for once-daily administration. Abrupt discontinuation should be avoided; taper gradually over 1–2 weeks to prevent rebound hypertension or angina.
Precautions
Patients with a history of bronchospasm, asthma, or COPD should use propranolol with extreme caution due to risk of bronchoconstriction. Use is contraindicated in severe bradycardia, heart block greater than first degree, and cardiogenic shock. Caution is advised in diabetics as propranolol may mask hypoglycemic symptoms. Hepatic or renal impairment necessitates dose adjustment. Elderly patients may require lower initial doses. Periodic monitoring of heart rate, blood pressure, ECG, and renal function is recommended during long-term therapy.
Contraindications
- Bronchial asthma or history of bronchospasm
- Severe bradycardia (heart rate <50 bpm)
- Second- or third-degree heart block
- Cardiogenic shock
- Decompensated heart failure
- Hypersensitivity to propranolol or any component of the formulation
- Severe peripheral arterial disease
- Pheochromocytoma (unless used with alpha-blockade)
Possible side effect
Common side effects include fatigue, dizziness, bradycardia, cold extremities, nausea, and sleep disturbances. Less frequently, patients may experience bronchospasm, heart failure exacerbation, depression, vivid dreams, or erectile dysfunction. Rare but serious adverse effects include severe hypotension, heart block, exacerbation of angina upon abrupt withdrawal, and hypoglycemia. Most side effects are dose-dependent and may diminish with continued use or dose reduction.
Drug interaction
Propranolol interacts with numerous medications. Concomitant use with calcium channel blockers (e.g., verapamil, diltiazem) may potentiate bradycardia and AV block. CYP2D6 inhibitors (e.g., fluoxetine, quinidine) can increase propranolol levels. It may enhance effects of insulin and oral hypoglycemics. Concurrent use with clonidine may exacerbate rebound hypertension. NSAIDs may diminish antihypertensive efficacy. Avoid use with other beta-agonists in patients with respiratory conditions.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. In that case, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one. Patients should be educated on maintaining consistent dosing to avoid fluctuations in therapeutic effect.
Overdose
Symptoms of overdose include severe bradycardia, hypotension, heart failure, bronchospasm, hypoglycemia, and seizures. Management involves close monitoring, intravenous fluids, atropine for bradycardia, glucagon for hypotension, and beta-agonists for bronchospasm. In severe cases, cardiac pacing or vasopressors may be required. Gastric lavage or activated charcoal may be considered if ingestion was recent.
Storage
Store at room temperature (15–30°C) in a tightly closed container, protected from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and professional reference only. It is not a substitute for clinical judgment or personalized medical advice. Prescribers should consult official prescribing information and relevant clinical guidelines before initiating therapy. Patients must follow their healthcare provider’s instructions and report any adverse effects promptly.
Reviews
Clinical studies and meta-analyses consistently support the efficacy and safety of propranolol across its indicated uses. In hypertension, it demonstrates reliable BP reduction with once-daily extended-release formulations improving adherence. For migraine prophylaxis, it reduces attack frequency by approximately 50% in responsive patients. Its role in anxiety management is well-documented, particularly for performance situations. Long-term use is generally well-tolerated, though individual response and side effect profiles vary. Ongoing research continues to explore expanded applications and optimized dosing strategies.